Profiling analysis of oligosaccharides in antibody pharmaceuticals by capillary electrophoresis.
about
In vitro and in vivo modifications of recombinant and human IgG antibodiesModern Technologies for Creating Synthetic Antibodies for Clinical application.Double knockdown of alpha1,6-fucosyltransferase (FUT8) and GDP-mannose 4,6-dehydratase (GMD) in antibody-producing cells: a new strategy for generating fully non-fucosylated therapeutic antibodies with enhanced ADCCAnalysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: An update for 2003-2004.Two mechanisms of the enhanced antibody-dependent cellular cytotoxicity (ADCC) efficacy of non-fucosylated therapeutic antibodies in human blood.Capillary electrophoretic separation of mono- and di-saccharides with dynamic pH junction and implementation in microchips.Molecular cloning, characterization, genomic organization and promoter analysis of the α1,6-fucosyltransferase gene (fut8) expressed in the rat hybridoma cell line YB2/0Alterations in glycopeptides associated with herceptin treatment of human breast carcinoma mcf-7 and T-lymphoblastoid cells2-DE and MALDI-TOF-MS analysis of therapeutic fusion protein abatacept.Highly sensitive capillary electrophoresis analysis of N-linked oligosaccharides in glycoproteins following fluorescence derivatization with rhodamine 110 and laser-induced fluorescence detection.LC-MS/MS biopharmaceutical glycoanalysis: identification of desirable reference material characteristics.Characterization of N-Linked Glycosylation in a Monoclonal Antibody Produced in NS0 Cells Using Capillary Electrophoresis with Laser-Induced Fluorescence DetectionSialic acid methylation refines capillary electrophoresis laser-induced fluorescence analyses of immunoglobulin G N-glycans of ovarian cancer patients.Capillary electrophoresis of acidic oligosaccharides from human milk.Evaluation of glycosylation for quality assurance of antibody pharmaceuticals by capillary electrophoresis.Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies.IgG glycosylation analysis.Glycan labeling strategies and their use in identification and quantification.Analysis of glycoforms on the glycosylation site and the glycans in monoclonal antibody biopharmaceuticals.Proposed mechanism of off-target toxicity for antibody-drug conjugates driven by mannose receptor uptake.The potential of the capillary electrophoresis techniques for quality control of biopharmaceuticals-a review.Quality control and stability studies with the monoclonal antibody, trastuzumab: application of 1D- vs. 2D-gel electrophoresis.Development and validation of an antibody-dependent cell-mediated cytotoxicity-reporter gene assay.Main Quality Attributes of Monoclonal Antibodies and Effect of Cell Culture ComponentsKinetics of N-Glycan Release from Human Immunoglobulin G (IgG) by PNGase F: All Glycans Are Not Created Equal.Online enzymatic sequencing of glycans from Trastuzumab by phospholipid-assisted capillary electrophoresis.Capillary electrophoresis-electrospray ionization mass spectrometry for rapid and sensitive N-glycan analysis of glycoproteins as 9-fluorenylmethyl derivatives.Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.
P2860
Q26859713-91C8C5FE-7902-4448-8A41-ED9867ED21C5Q30467308-F996E1FD-352D-46B8-83F7-BC2D4325A388Q33307815-F819C90F-3078-40BC-BA19-F5B02017F25EQ33372831-9A94F91A-602A-4CB1-97A7-8292A9A9A150Q33410392-410A859E-189E-4DD8-B740-5A94C3B21E62Q33592323-604F33D6-13BD-49CC-B075-B8A184BDCFFDQ33786180-472C138E-3FE1-4B25-98A9-E91A99082723Q33910762-E32A61B2-BDA9-4323-A777-8384DFFA73E0Q33917081-A6EA86B2-A881-48A6-83C0-C80307D8883FQ34105021-2B6D840F-1777-4D9B-AD78-C3F5E8716998Q34165960-A0C03ACF-1424-49F8-83D6-6B1FAD33460CQ35052763-A85D8351-C35F-4B0C-BFB2-1E260E308DB1Q35165824-22544576-E6C1-46DF-B36C-B44389EA7F2EQ37177392-F56582D7-5F5D-431D-A1BF-A8999A4D7887Q37273597-A582E25D-C9ED-4433-A074-E946D633AF8CQ37323537-75DC5953-B103-4423-B3B6-1F92F9519B61Q37391496-1638D35C-3549-4F68-83A8-7CBEA2B7AA14Q37708129-868E522B-E107-4B77-9994-97D384DAA9CBQ37972871-A7799212-FDE1-4B17-8CC7-86C079F54E02Q38065955-DA67A2AF-1F0C-4B11-B8A2-90D7191FDD87Q38287278-A0E82E57-AFF3-4265-B8AE-B8110836969BQ39357941-9DDE907E-E2FD-4D10-A7D3-BAB2AFD30C04Q41868216-04E7F91D-7EE7-4F2C-A6F6-80B602ACBC2FQ42363063-E132AAAA-811E-4405-BB4B-D3D501C99F1FQ42372965-26B7198B-4095-4CAA-B993-1E686C93CE3EQ44970905-DB841DC8-ADF5-4DD2-85FD-172D911F6F90Q46291586-5D5D4B5D-5FD0-42C5-813F-78FDCC4D4370Q51773472-A1DFF8F8-C3A8-4757-BCE3-553B55C5D6C6
P2860
Profiling analysis of oligosaccharides in antibody pharmaceuticals by capillary electrophoresis.
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Profiling analysis of oligosac ...... by capillary electrophoresis.
@ast
Profiling analysis of oligosac ...... by capillary electrophoresis.
@en
type
label
Profiling analysis of oligosac ...... by capillary electrophoresis.
@ast
Profiling analysis of oligosac ...... by capillary electrophoresis.
@en
prefLabel
Profiling analysis of oligosac ...... by capillary electrophoresis.
@ast
Profiling analysis of oligosac ...... by capillary electrophoresis.
@en
P2093
P921
P1476
Profiling analysis of oligosac ...... by capillary electrophoresis.
@en
P2093
Chie Nomura
Kazuaki Kakehi
Mitsuhiro Kinoshita
Nana Kawasaki
Rika Ishikawa
Saori Nishiura
Satoru Kamoda
Takao Hayakawa
P304
P356
10.1016/J.CHROMA.2004.08.049
P407
P577
2004-10-01T00:00:00Z